Your browser doesn't support javascript.
The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute the simple solution. Author's reply.
Hofmaenner, Daniel A; Singer, Mervyn.
  • Hofmaenner DA; Bloomsbury Institute of Intensive Care Medicine, Division of Medicine, University College London, Cruciform Building, Gower St, London, WC1E 6BT, UK.
  • Singer M; Bloomsbury Institute of Intensive Care Medicine, Division of Medicine, University College London, Cruciform Building, Gower St, London, WC1E 6BT, UK. m.singer@ucl.ac.uk.
Intensive Care Med ; 48(8): 1118-1119, 2022 08.
Article in English | MEDLINE | ID: covidwho-1966119

Full text: Available Collection: International databases Database: MEDLINE Main subject: Venous Thromboembolism / Anticoagulants Limits: Humans Language: English Journal: Intensive Care Med Year: 2022 Document Type: Article Affiliation country: S00134-022-06768-0

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Venous Thromboembolism / Anticoagulants Limits: Humans Language: English Journal: Intensive Care Med Year: 2022 Document Type: Article Affiliation country: S00134-022-06768-0